SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-009302
Filing Date
2017-12-12
Accepted
2017-12-12 16:16:28
Documents
54
Period of Report
2017-10-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpmx-20171031x10q.htm 10-Q 1677566
2 EX-10.1 bpmx-20171031ex101b1d98d.htm EX-10.1 31685
3 EX-31.1 bpmx-20171031ex3116d0895.htm EX-31.1 19303
4 EX-31.2 bpmx-20171031ex312030905.htm EX-31.2 19310
5 EX-32.1 bpmx-20171031ex321720008.htm EX-32.1 11499
  Complete submission text file 0001558370-17-009302.txt   5807582

Data Files

Seq Description Document Type Size
6 EX-101.INS bpmx-20171031.xml EX-101.INS 1151142
7 EX-101.SCH bpmx-20171031.xsd EX-101.SCH 37601
8 EX-101.CAL bpmx-20171031_cal.xml EX-101.CAL 35722
9 EX-101.DEF bpmx-20171031_def.xml EX-101.DEF 160814
10 EX-101.LAB bpmx-20171031_lab.xml EX-101.LAB 329678
11 EX-101.PRE bpmx-20171031_pre.xml EX-101.PRE 291077
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 171251921
SIC: 2834 Pharmaceutical Preparations